Skip to: Content
Skip to: Site Navigation
Skip to: Search

May 17, 2008 12:37:46 AM CDT



J&J Hid Birth Control Patch Risks: Suit  

Posted Apr 6, 08 4:40 PM CDT in Science & Health    Most Covered

(newser) – Johnson & Johnson doctored data to get its birth control patch FDA-approved, according to a class action lawsuit that claims Ortho-Evra caused blood clots, heart attacks, and strokes. A J&J scientist allegedly doctored the data with a "correction factor" for the FDA, lowering estrogen-related risk by 60%: He "presented a truly misleading picture of the amount of estrogen delivered by the patch,'' the suit said.

The company altered data because it was "desperate" to market the product before its patent on the birth control pill ran out, lawyers on behalf of some 2,400 women charged. They also accuse J&J of manufacturing irregularities that made the patch's estrogen levels unstable. J&J argues that FDA approval preempts the women's right to sue, Bloomberg reports.

Source Bloomberg

open commentscomments (0)

Editor Recommended

More on pre-emption and the J&J case
New York Times | Apr 6, 08

Men and birth control
US News and World Report | Mar 28, 08

J&J Hid Birth Control Patch Risks: Suit
The Orth-Evra birth control patch releases higher estrogen levels according to what area of the body it's applied to.   (Shutterstock)
J&J Hid Birth Control Patch Risks: Suit
The Ortho-Evra birth control patch may release 60% more estrogen than the pill.   (Shutterstock)
prev   next
play

Threads (1 of 2)



Loading...

Loading...

Today's Most Popular

Loading...

Other Science & Health Stories

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »